Co-Authors
This is a "connection" page, showing publications co-authored by JENNIFER LITTON and JOHN VICTOR HEYMACH.
Connection Strength
0.222
-
First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1). J Immunother Cancer. 2023 03; 11(3).
Score: 0.222
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.